Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec;17(12):110.
doi: 10.1007/s11886-015-0666-9.

Risk Stratification for Primary Prevention of Coronary Artery Disease: Roles of C-Reactive Protein and Coronary Artery Calcium

Affiliations
Review

Risk Stratification for Primary Prevention of Coronary Artery Disease: Roles of C-Reactive Protein and Coronary Artery Calcium

Waqas T Qureshi et al. Curr Cardiol Rep. 2015 Dec.

Abstract

Risk stratification of individuals at risk for atherosclerotic cardiovascular disease (ASCVD) plays an important role in primary prevention of cardiovascular disease. In addition to risk scores derived from conventional cardiovascular risk factors, high sensitivity C-reactive protein (hs-CRP) and coronary artery calcium (CAC) have emerged as two of the widely accepted non traditional risk factors for atherosclerotic disease that have shown incremental prognostic value in predicting cardiovascular events. This review systematically assesses the role of hs-CRP and CAC in various studies and demonstrates meta-analyses of the incremental prognostic value of hs-CRP and CAC in identifying patients at risk of future CVD events. Compared with this, CAC showed better incremental prognostic value and might be a better indicator of ASCVD risk in asymptomatic adults.

Keywords: Cholesterol treatment; Coronary artery calcium; Epidemiology; High sensitivity C reactive protein; Review; Risk factors; Statin therapy.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 2008 Mar 27;358(13):1336-45 - PubMed
    1. Lancet. 1997 Feb 15;349(9050):462-6 - PubMed
    1. Cardiovasc Res. 2001 Nov;52(2):281-9 - PubMed
    1. Circulation. 2007 Feb 27;115(8):981-9 - PubMed
    1. BMJ. 2012 May 24;344:e3318 - PubMed

MeSH terms

Substances

LinkOut - more resources